HSBC Downgrades Novo Nordisk (NVO.US) Rating to "Hold" with 2025 Growth Expectations Cut
We have learned from HSBC that it has downgraded its rating on Novo Nordisk (NVO.US) from \"Buy\" to \"Hold\", citing the company\'s latest warning on its business outlook for 2025. The management of